CORONAVIRUS INFO PROVIDED BY DR. JIM HARRIS – 8/15/2020

August 15, 2020

New Cases Friday: Harrison-0.     Gregg 14

FROM THE LONGVIEW PAPER’ Friday:”Hospitalizations in Longview related to COVID-19 have increased to 123 — up from 119 reported Monday, Browne said. He added that not all of those patients live in Gregg County.

Browne also noted a trend of younger people without underlying health issues needing to be hospitalized and moved into intensive care units.”The fact that younger people are getting it and becoming sicker is a concern,”

SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report    In summary, this case emphasises the use of SARS-CoV-2 PCR testing of skin biopsy samples as an additional diagnostic tool, helping to shed light on the actual prevalence of COVID-19 in the general population. Additionally, further studies are needed to understand to what extent and at what point during their disease course patients with COVID-19 actually develop immunity—a question of uttermost importance, especially with regards to the currently ongoing efforts to develop a vaccine to SARS-CoV-2, and the concept of herd immunity generation.

   FROM JOHNS HOPKINS

1. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 (Cell) Researchers systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in unexposed individuals, exposed family members, and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent-phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. The collective dataset shows that SARS-CoV-2 elicits robust, broad, and highly functional memory T cell responses, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19.2.Exclusive: U.S. to Make Coronavirus Strain for Possible Human Challenge Trials (Reuters) U.S. government scientists have begun efforts to manufacture a strain of the novel coronavirus that could be used in human challenge trials of vaccines, a controversial type of study in which healthy volunteers would be vaccinated and then intentionally infected with the virus.The work is preliminary and such trials would not replace large-scale, Phase 3 trials such as those now underway in the United States testing experimental COVID-19 vaccines from Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N), according to a statement emailed to Reuters by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.Covid-19 “long haulers” are organizing online to study themselves

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
 In this interim report of phase 1 and phase 2 trials of an inactivated COVID-19 vaccine, patients had a low rate of adverse reactions and demonstrated immunogenicity; the study is ongoing. Efficacy and longer-term adverse event assessment will require phase 3 trials.

If life were fair, Elvis would still be alive today and all the impersonators would be dead.
~ Johnny Carson

GIVE US YOUR FEEDBACK.  CLICK ON “COMMENT” TO TELL US WHAT YOU THINK or use one of the alternative methods for providing feedback.

click here to CLOSE THIS PAGE

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s